LegalizeCommission Implementing Regulation (EU) 2021/404 of 24 March 2021 laying down the lists of third countries, territories or zones thereof from which the entry into the Union of animals, germinal products and products of animal origin is permitted in accordance with Regulation (EU) 2016/429 of the European Parliament and the Council (Text with EEA relevance)
PART 3
Specific conditions referred to in column 4 of the table set out in Section B of Part 1
| P1 | Suspension of entry into the Union due to restrictions related to (an) outbreak(s) of highly pathogenic avian influenza. |
|---|---|
| P2 | Suspension of entry into the Union due to restrictions related to (an) outbreak(s) of infection with Newcastle disease virus. |
| N | Guarantees have been provided that the legislation on the control of infection with Newcastle disease virus in the third country or territory or zone thereof is equivalent to that applied in the Union. In the case of an outbreak of infection with Newcastle disease virus, entry into the Union may continue to be authorised from the third country or territory or zone thereof with no change in the third country code or territory code or zone code. However, the entry into the Union from any areas which are placed under official restrictions by the competent authority of the third country or territory concerned due to an outbreak of that disease shall be automatically prohibited. |
PART 4
Animal health guarantees referred to in column 5 of the table set out in Section B of Part 1
| A | Third country or territory in which vaccination against highly pathogenic avian influenza is carried out and the competent authority has provided guarantees in accordance with point (c) of Article 37 of Delegated Regulation (EU) 2020/692. |
|---|---|
| B | Third country or territory in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria set out in point 1 of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited and the competent authority has provided guarantees that the poultry meet the animal health requirements set out in point 2 of Annex XV to Delegated Regulation (EU) 2020/692, in accordance with point (e) of Article 37 of Delegated Regulation (EU) 2020/692. |
| C | Third country or territory authorised for the entry into the Union of ratites which is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692 and the competent authority has provided guarantees in accordance with the second indent of point (d)(ii) of Article 37 of Delegated Regulation (EU) 2020/692 for the relevant commodity. |
ANNEX VI
PART 1
List of third countries, territories or zones thereof authorised for the entry into the Union of consignments of captive birds and germinal products of captive birds as referred to in point (1)(e) of Article 3
SECTION A
List of third countries or territories, or zones thereof authorised for the entry into the Union of consignments of captive birds and germinal products of captive birds, other than captive birds referred to in Article 62 of Delegated Regulation (EU) 2020/692, as referred to in Article 3(1), point (e)(i), of this Regulation
| ISO code and name of the third country or territory | Zone as set out in Part 2 | Categories permitted to enter the Union | Animal health certificate | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 | Closing date | Opening date |
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| AR Argentina | AR-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| AU Australia | AU-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| BR Brazil | BR-0 | - | - | ||||
| BR-1 | Captive birds | CAPTIVE-BIRDS | |||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| CA Canada | CA-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| CH Switzerland | CH-0 | Subject to the Agreement referred to in point 7 of Annex I | |||||
| CL Chile | CL-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| GB United Kingdom | GB-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| GG Guernsey | GG-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| IL Israel | IL-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| IM Isle of Man | IM-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| JE Jersey | JE-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| NZ New Zealand | NZ-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| PH Philippines | PH-0 | - | - | ||||
| PH-1 | Captive birds | CAPTIVE-BIRDS | |||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| TN Tunisia | TN-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS | ||||||
| USA United States | US-0 | Captive birds | CAPTIVE-BIRDS | ||||
| Hatching eggs of captive birds | HE-CAPTIVE-BIRDS |
SECTION B
List of third countries or territories, or zones thereof authorised for the entry into the Union of consignments of captive birds and germinal products of captive birds based on equivalent guarantees in accordance with Article 62(1) of Delegated Regulation (EU) 2020/692 as referred to in Article 3(1), point (e)(ii), of this Regulation
| ISO code and name of the third country or territory | Zone as set out in Part 2 | Categories permitted to enter the Union | Animal health certificate | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 | Closing date | Opening date |
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| AD Andorra | AD-0 | Captive birds | - | ||||
| Hatching eggs of captive birds | - | ||||||
| CH Switzerland | CH-0 | Captive birds | - | ||||
| Hatching eggs of captive birds | - | ||||||
| LI Liechtenstein | LI-0 | Captive birds | - | ||||
| Hatching eggs of captive birds | - | ||||||
| MC Monaco | MC-0 | Captive birds | - | ||||
| Hatching eggs of captive birds | - | ||||||
| SM San Marino | SM-0 | Captive birds | - | ||||
| Hatching eggs of captive birds | - | ||||||
| VA Vatican City State | VA-0 | Captive birds | - | ||||
| Hatching eggs of captive birds | - |
PART 2
Descriptions of zones of third countries or territories referred to in column 2 of the table set out in Part 1
| Name of the third country or territory | Code of the zone | Description of the zone |
|---|---|---|
| Brazil | BR-1 | States of: Mato Grosso, Paraná, Rio Grande do Sul, Santa Catarina and São Paulo |
| Philippines | PH-1 | National Capital Region |
PART 3
Specific conditions referred to in column 5 of the table set out in Part 1
None
PART 4
Animal health guarantees referred to in column 6 of the table set out in Part 1
None
ANNEX VII
PART 1
List of third countries, territories or zones thereof authorised for the entry into the Union of consignments of queen honeybees and bumble bees as referred to in point (1)(f) of Article 3
| ISO code and name of the third country or territory | Code of the zone as set out in Part 2 | Categories permitted to enter the Union | Animal health certificates | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 | Closing date | Opening date |
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| AR Argentina | AR-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| AU Australia | AU-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| CA Canada | CA-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| CH Switzerland | CH-0 | Subject to the Agreement referred to in point 7 of Annex I | |||||
| CL Chile | CL-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| CR Costa Rica | CR-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| GB United Kingdom | GB-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| GG Guernsey | GG-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| IL Israel | IL-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| IM Isle of Man | IM-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| JE Jersey | JE-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| KE Kenya | KE-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| MA Morocco | MA-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| MK Republic of North Macedonia | MK-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| MX Mexico | MK-0 | Bumble bees | BBEE | ||||
| NC New Caledonia | NC-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| NZ New Zealand | NZ-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| RS Serbia | RS-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| RU Russia | RU-0 | Queen honeybees and bumble bees | QUE, BEE | ||||
| TR Turkey | TR-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| UA Ukraine | UA-0 | Queen honeybees and bumble bees | QUE, BBEE | ||||
| US United States | US-0 | Bumble bees | BBEE | ||||
| ZA South Africa | ZA-0 | Queen honeybees and bumble bees | QUE, BBEE |
PART 2
Descriptions of zones of third countries or territories referred to in column 2 of the table set out in Part 1
None
PART 3
Specific conditions referred to in column 5 of the table set out in Part 1
None
PART 4
Animal health guarantees referred to in column 6 of the table set out in Part 1
| VAR | The Union has recognised freedom from infestation with Varroa spp. (Varroosis)of the third country, territory or zone in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
|---|---|
ANNEX VIII
PART 1
List of third countries or territories, or zones thereof authorised for the entry into the Union of consignments of dogs, cats and ferrets as referred to in Article 3(1), point (g)
| ISO code and name of the third country or territory | Code of the zone as set out in Part 2 | Species and categories permitted to enter the Union | Animal health certificates | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 | Closing date | Opening date |
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| AC Ascension Island | AC-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| AD Andorra | AD-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| AE United Arab Emirates | AE-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| AG Antigua and Barbuda | AG-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| AL Albania | AL-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| AR Argentina | AR-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| AU Australia | AU-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| AW Aruba | AW-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| BA Bosnia and Herzegovina | BA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| BB Barbados | BB-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| BH Bahrain | BH-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| BM Bermuda | BM-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| BO Bolivia | BO-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| BQ Bonaire, Saint Eustatius and Saba (the Bes Islands) | BQ-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| BR Brazil | BR-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| BW Botswana | BW-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| BY Belarus | BY-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| BZ Belize | BZ-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| CA Canada | CA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| CH Switzerland | CH-0 | Subject to the Agreement referred to in point 7 of Annex I | |||||
| CL Chile | CL-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| CN China | CN-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| CO Colombia | CO-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| CR Costa Rica | CR-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| CU Cuba | CU-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| CW Curacao | CW-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| DZ Algeria | DZ-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| EG Egypt | EG-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| ET Ethiopia | ET-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| FJ Fiji | FJ-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| FK Falkland Islands | FK-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| FO Faroe Islands | FO-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| GB United Kingdom | GB-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| GG Guernsey | GG-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| GI Gibraltar | GI-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| GL Greenland | GL-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| GT Guatemala | GT-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| HK Hong Kong | HK-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| HN Honduras | HN-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| IL Israel | IL-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| IM Isle of Man | IM-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| IN India | IN-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| IS Iceland | IS-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| JE Jersey | JE-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| JM Jamaica | JM-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| JO Jordan | JO-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| JP Japan | JP-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| KE Kenya | KE-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| KG Kyrgyzstan | KG-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| KN Saint Kitts and Nevis | KN-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| KR Korea Republic | KR-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| KW Kuwait | KW-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| KY Cayman Islands | KY-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| LB Lebanon | LB-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| LC Saint Lucia | LC-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| LI Liechtenstein | LI-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| MA Morocco | MA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| MC Monaco | MC-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| ME Montenegro | ME-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| MG Madagascar | MG-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| MK North Macedonia | MK-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| MO Macao | MO-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| MS Montserrat | MS-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| MU Mauritius | MU-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| MX Mexico | MX-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| MY Malaysia | MY-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| NA Namibia | NA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| NC New Caledonia | NC-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| NI Nicaragua | NI-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| NZ New Zealand | NZ-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| OM Oman | OM-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| PA Panama | PA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| PE Peru | PE-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| PF French Polynesia | PF-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| PM Saint Pierre et Miquelon | PM-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| PY Paraguay | PY-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| QA Qatar | QA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| RS Serbia | RS-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| RU Russia | RU-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| SA Saudi Arabia | SA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| SG Singapore | SG-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| SH Saint Helena | SH-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| SM San Marino | SM-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| SV El Salvador | SV-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| SX Sint Maarten | SX-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| SZ Eswatini | SZ-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| TH Thailand | TH-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| TN Tunisia | TN-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| TR Turkey | TR-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| TT Trinidad and Tobago | TT-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| TW Taiwan | TW-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| UA Ukraine | UA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| US United States, including American Samoa, Guam, Northern Mariana Islands, Puerto Rico and US Virgin Islands | US-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| UY Uruguay | UY-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| VA Vatican City State | VA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| VC Saint Vincent and the Grenadines | VC-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| VG British Virgin Islands | VG-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| VU Vanuatu | VU-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| WF Wallis and Futuna | WF-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | ||||
| ZA South Africa | ZA-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test | |||
| ZW Zimbabwe | ZW-0 | Dogs, cats and ferrets for commercial purposes | CANIS-FELIS-FERRETS | Rabies antibody titration test |
PART 2
Descriptions of zones of third countries or territories referred to in column 2 of the table set out in Part 1
None
PART 3
Specific conditions referred to in column 5 of the table set out in Part 1
| Rabies antibody titration test | The animals of the consignment entering the Union must have undergone valid rabies antibody titration test, in accordance with point 1 of Annex XXI of Delegated Regulation (EU) 2020/692 |
|---|---|
PART 4
Animal health guarantees referred to in column 6 of the table set out in Part 1
| ECH | The Union has recognised freedom from infestation with Echinococcus multilocularis of the third country, territory or zone in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
|---|---|
ANNEX IX
PART 1
List of third countries, territories or zones thereof authorised for the entry into the Union of consignments of germinal products of bovine animals as referred to in point (1)(h) of Article 3
| ISO code and name of the third country or territory | Code of the zone as set out in Part 2 | Categories of germinal products permitted to enter the Union | Animal health certificates | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 |
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 |
| AR Argentina | AR-0 | Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | ||
| AU Australia | AU-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | EHD-test BTV-test | |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | EHD-test BTV-test | |||
| CA Canada | CA-0 | Semen | Commission Decision 2005/290/EC | SF-BTV SF-EHD EHD-test BTV-test | |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | SF-BTV SF-EHD EHD-test BTV-test | |||
| CH Switzerland | CH - 0 | Semen | Subject to the Agreement referred to in point 7 of Annex I | ||
| Oocytes and embryos | |||||
| CL Chile | CL - 0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | ||
| GB United Kingdom | GB-1 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | BRU EBL BTV-test |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| GB-2 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | BRU TB EBL BTV-test | |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| GG Guernsey | GG-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| GL Greenland | GL - 0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | ||
| IL Israel | IL-0 | Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | ||
| IS Iceland | IS-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | ||
| IM Isle of Man | IM-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | BRU TB EBL |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| JE Jersey | JE-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | EBL |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| MK North Macedonia | MK-0 | Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | BTV-test | |
| NZ New Zealand | NZ-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | TB, BRU, BTV | |
| Oocytes and embryos | Annex I to Commission Implementing Decision (EU) 2015/1901 BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | TB, BRU, BTV | |||
| PM Saint Pierre et Miquelon | PM-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | ||
| US United States | US-0 | Semen | BOV-SEM-A-ENTRY BOV-SEM-B-ENTRY BOV-SEM-C-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | EHD-test BTV-test | |
| Oocytes and embryos | BOV-OOCYTES-EMB-A-ENTRY BOV-in-vivo-EMB-B-ENTRY BOV-in-vitro-EMB-C-ENTRY BOV-in-vitro-EMB-D-ENTRY BOV-GP-PROCESSING-ENTRY BOV-GP-STORAGE-ENTRY | EHD-test BTV-test |
PART 2
Descriptions of zones of third countries or territories referred to in column 2 of the table set out in Part 1
| Name of the third country or territory | Code of the zone | Description of the zone |
|---|---|---|
| United Kingdom | GB-1 | England and Wales |
| GB-2 | Scotland |
PART 3
Specific conditions referred to in column 5 of the table set out in Part 1
| Period before 1 January 2021 | The model certificates to be used for entry into the Union of semen, oocytes and embryos from the zone referred to in column 2 of the table set out in Part 1 collected or produced, processed and stored before 1 January 2021 are set out in Chapters 24, 25, 27, 28 and 29 of Annex I to Commission Implementing Regulation (EU) 2021/403 (*1) |
|---|---|
| (*1) Commission Implementing Regulation (EU) 2021/403 of 24 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1). |
PART 4
Animal health guarantees referred to in column 6 of the table set out in Part 1
| EHD-test | Compulsory testing for infection with epizootic haemorrhagic disease virus – consignments of semen, in vitro produced embryos and oocytes |
|---|---|
| BTV-test | Compulsory testing for infection with bluetongue virus– consignments of semen, in vitro produced embryos and oocytes |
| BRU | The Union has recognised freedom from infection with Brucella abortus, B. melitensis and B. suis of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| TB | The Union has recognised freedom from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| BTV | The Union has recognised freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| SF-BTV | The Union has recognised seasonal freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| SF-EHD | The Union has recognised seasonal freedom from infection with epizootic haemorrhagic disease virus of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| EBL | The Union has recognised freedom from enzootic bovine leukosis of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
ANNEX X
PART 1
List of third countries, territories or zones thereof authorised for the entry into the Union of consignments of germinal products of ovine and caprine animals as referred to in point (1)(i) of Article 3
| ISO code and name of the third country or territory | Code of the zone as set out in Part 2 | Categories of germinal products permitted to enter the Union | Animal health certificates | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 |
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 |
| AU Australia | AU-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | EHD-test BTV-test | |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | EHD-test BTV-test | |||
| CA Canada | CA-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | BRU SF-BTV SF-EHD EHD-test BTV-test | |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | BRU SF-BTV SF-EHD EHD-test BTV-test | |||
| CH Switzerland | CH - 0 | Semen | Subject to the Agreement referred to in point 7 of Annex I | ||
| Oocytes and embryos | |||||
| CL Chile | CL-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | BRU | |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | BRU | |||
| GB United Kingdom | GB-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | BRU BTV-test |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| GG Guernsey | GG-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | BRU |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| GL Greenland | GL - 0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | ||||
| IM Isle of Man | IM-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | BRU |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| IS Iceland | IS-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | ||||
| JE Jersey | JE-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| NZ New Zealand | NZ-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | BRU, BTV | |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | BRU, BTV | |||
| PM Saint Pierre et Miquelon | PM-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | ||||
| US United States | US-0 | Semen | OV/CAP-SEM-A-ENTRY OV/CAP-SEM-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | EHD-test BTV-test | |
| Oocytes and embryos | OV/CAP-OOCYTES-EMB-A-ENTRY OV/CAP-OOCYTES-EMB-B-ENTRY OV/CAP-GP-PROCESSING-ENTRY OV/CAP-GP-STORAGE-ENTRY | EHD-test BTV-test |
PART 2
Descriptions of zones of third countries or territories referred to in column 2 of the table set out in Part 1
None
PART 3
Specific conditions referred to in column 5 of the table set out in Part 1
| Period before 1 January 2021 | The model certificates to be used for entry into the Union of semen, oocytes and embryos from the zone referred to in column 2 of the table set out in Part 1 collected or produced, processed and stored before 1 January 2021 are set out in Chapters 31 and 32 and Chapters 34 to 37 of Annex I to Implementing Regulation (EU) 2021/403 |
|---|---|
PART 4
Animal health guarantees referred to in column 6 of the table set out in Part 1
| EHD-test | Compulsory testing for infection with epizootic haemorrhagic disease virus |
|---|---|
| BTV-test | Compulsory testing for infection with bluetongue virus |
| BRU | The Union has recognised freedom from infection with Brucella abortus, B. melitensis and B. suis of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| BTV | The Union has recognised freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| SF-BTV | The Union has recognised seasonal freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
| SF-EHD | The Union has recognised seasonal freedom from infection with epizootic haemorrhagic disease virus of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
ANNEX XI
PART 1
List of third countries, territories or zones thereof authorised for the entry into the Union of consignments of germinal products of porcine animals as referred to in point (1)(j) of Article 3
| ISO code and name of the third country or territory | Code of the zone as set out in Part 2 | Categories of germinal products permitted to enter the Union | Animal health certificates | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 |
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 |
| CA Canada | CA- 0 | Semen | POR-SEM-A-ENTRY POR-SEM-B-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | POR-OOCYTES-EMB-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | ||||
| CH Switzerland | CH - 0 | Semen | Subject to the Agreement referred to in point 7 of Annex I | ||
| Oocytes and embryos | |||||
| GB United Kingdom | GB-0 | Semen | POR-SEM-A-ENTRY POR-SEM-B-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | ADV |
| Oocytes and embryos | POR-OOCYTES-EMB-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| GG Guernsey | GG-0 | Semen | POR-SEM-A-ENTRY POR-SEM-B-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | ADV |
| Oocytes and embryos | POR-OOCYTES-EMB-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| IM Isle of Man | IM-0 | Semen | POR-SEM-A-ENTRY POR-SEM-B-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | POR-OOCYTES-EMB-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| JE Jersey | JE-0 | Semen | POR-SEM-A-ENTRY POR-SEM-B-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | POR-OOCYTES-EMB-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| NZ New Zealand | NZ-0 | Semen | POR-SEM-A-ENTRY POR-SEM-B-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | POR-OOCYTES-EMB-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | ||||
| US United States | US-0 | Semen | POR-SEM-A-ENTRY POR-SEM-B-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | POR-OOCYTES-EMB-ENTRY POR-GP-PROCESSING-ENTRY POR-GP-STORAGE-ENTRY |
PART 2
Descriptions of zones of third countries or territories referred to in column 2 of the table set out in Part 1
None
PART 3
Specific conditions referred to in column 5 of the table set out in Part 1
| Period before 1 January 2021 | The model certificates to be used for entry into the Union of semen, oocytes and embryos from the zone referred to in column 2 of the table set out in Part 1 collected or produced, processed and stored before 1 January 2021 are set out in Chapter 39 and Chapters 41 to 44 of Annex I to Implementing Regulation (EU) 2021/403 |
|---|---|
PART 4
Animal health guarantees referred to in column 6 of the table set out in Part 1
| ADV | The Union has recognised freedom from infection with Aujeszky’s disease virus of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692 |
|---|---|
ANNEX XII
PART 1
List of third countries, territories or zones thereof authorised for the entry into the Union of consignments of germinal products of equine animals as referred to in point (1)(k) of Article 3
| ISO code and name of the third country or territory | Code of the zone as set out in Part 2 | Categories of equine animals of origin of the germinal products permitted to enter the Union | Categories of germinal products permitted to enter the Union | Animal health certificates | Specific conditions as set out in Part 3 | Animal health guarantees as set out in Part 4 |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| AE United Arab Emirates | AE-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| AR Argentina | AR-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| AU Australia | AU-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| CA Canada | CA-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| CH Switzerland | CH-0 | All categories | All categories | Subject to the Agreement, as referred to in point 7 of Annex I | ||
| GB United Kingdom | GB-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Other equine animals not intended for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| GG Guernsey | GG-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Other equine animals not intended for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| IL Israel | IL-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| IM Isle of Man | IM-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Other equine animals not intended for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| IS Iceland | IS-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| JE Jersey | JE-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| Other equine animals not intended for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | |||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A-ENTRY EQUI-OOCYTES-EMB-B-ENTRY EQUI-OOCYTES-EMB-C-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | Period before 1 January 2021 | ||||
| MA Morocco | MA-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| QA Qatar | QA-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| SA Saudi Arabia | SA-1 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| UA Ukraine | UA-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| US United States | US-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Oocytes and embryos | EQUI-OOCYTES-EMB-A- ENTRY EQUI-OOCYTES-EMB-B- ENTRY EQUI-OOCYTES-EMB-C- ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | |||||
| UY Uruguay | UY-0 | Registered horses | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||
| Registered equidae | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY | ||||
| Other equine animals not for slaughter | Semen | EQUI-SEMEN-A-ENTRY EQUI-SEMEN-B-ENTRY EQUI-SEMEN-C-ENTRY EQUI-SEMEN-D-ENTRY EQUI-GP-PROCESSING-ENTRY EQUI-GP-STORAGE-ENTRY |
PART 2
Descriptions of zones of third countries or territories referred to in column 2 of the table set out in Part 1
The descriptions provided in the table set out in Part 2 of Annex IV apply.
PART 3
Specific conditions referred to in column 6 of the table set out in Part 1
| Period before 1 January 2021 | The model certificates to be used for entry into the Union of semen, oocytes and embryos from the zone referred to in column 2 of the table set out in Part 1 collected or produced, processed and stored before 1 January 2021 are set out in Chapters 46, 47 and 48 and Chapters 50 to 54 of Annex I to Implementing Regulation (EU) 2021/403 |
|---|---|
PART 4
Animal health guarantees referred to in column 7 of the table set out in Part 1
None
ANNEX XIII
PART 1
List of third countries, territories or zones thereof authorised for the entry into the Union of consignments of fresh meat of ungulates as referred to in point (1)(l) of Article 3
Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.
This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence.
EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.